![]() CB07-Exatecan structure
|
Common Name | CB07-Exatecan | ||
---|---|---|---|---|
CAS Number | 2879247-31-9 | Molecular Weight | 1472.56 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C71H94FN11O22 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CB07-ExatecanCB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exatecan and trastuzumab inhibits the growth of HER2-positive cancer cells. CB07-Exatecan can be used in cancer research[1]. |
Name | CB07-Exatecan |
---|
Description | CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exatecan and trastuzumab inhibits the growth of HER2-positive cancer cells. CB07-Exatecan can be used in cancer research[1]. |
---|---|
Related Catalog | |
References |
[1]. Weijia Tang, et al. Method for treating her2-positive solid tumor. Patent WO2023198079A1. |
Molecular Formula | C71H94FN11O22 |
---|---|
Molecular Weight | 1472.56 |